Does RUXOLITINIB Cause Mean cell volume abnormal? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Mean cell volume abnormal have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
45
Reports of Mean cell volume abnormal with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Mean cell volume abnormal From RUXOLITINIB?
Of the 45 reports, 1 (2.2%) resulted in death, 6 (13.3%) required hospitalization.
Is Mean cell volume abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Mean cell volume abnormal?
NIRAPARIB (17)
CARBOPLATIN (15)
PEMBROLIZUMAB (15)
RIBOCICLIB (15)
CLOZAPINE (14)
ECULIZUMAB (14)
ADALIMUMAB (12)
PACLITAXEL (12)
PALBOCICLIB (12)
METHOTREXATE (11)
Which RUXOLITINIB Alternatives Have Lower Mean cell volume abnormal Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE